<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: The regulation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> as a distinctive form of cell <z:hpo ids='HP_0011420'>death</z:hpo> and proliferation in the process of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate regulation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, proliferation and the participation of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene p53, we examined these parameters in Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLOGY: Apoptotic cells were identified and quantified in tissue specimens of 45 patients with different stages of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath> fundus epithelium, respectively, using the in situ end-labeling and electron microscopy method in combination with morphological criteria </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene p53 was examined by direct sequencing of exon 4-8 as well as immunohistochemically </plain></SENT>
<SENT sid="4" pm="."><plain>The proliferative activity was assessed by Ki67 immunostaining </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo>, identified by the in situ end-labeling and ultrastructural technique was significantly increased in Barrett's epithelium with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> than in specimens with <z:mpath ids='MPATH_458'>normal</z:mpath> fundic epithelium and Barrett's <z:mp ids='MP_0002038'>carcinomas</z:mp> (P &lt; 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>The proliferative activity, defined as Ki67 labeling index, was highest in <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>P53 mutations were found in 8/9 <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> and 2/5 specimens with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was lower in p53 positive specimens of the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp>-sequence than in p53 negative specimens of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The higher levels of both <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation indicate an increased cell turnover in Barrett's epithelium </plain></SENT>
<SENT sid="10" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> seems to maintain tissue homeostasis, which is regulated by p53, and gradually lost in the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp>-sequence of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>